Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.2K
Overview
44.2K
Cancer Vaccines01:30

Cancer Vaccines

347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

228
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
228

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of Dengue Fever in Pakistan.

PloS one·2026
Same author

Measuring antenatal care timing and content across 131 low-income and middle-income countries, 1995-2023: a systematic analysis of trends.

The Lancet. Global health·2026
Same author

Correction: Racial disparity in mortality from tuberculosis in the US between states with and without a history of Jim‑Crow laws: an analysis of the Global Burden of Disease (GBD) and risk factors study, 1990 to 2019.

BMC public health·2026
Same author

Breast cancer mortality by age and race and/or ethnicity across counties in the United States, 2000-2019.

Journal of the National Cancer Institute·2026
Same author

Burden of non-communicable diseases among adolescents and young adults aged 10-24 years in Middle East and North Africa, 1990-2023: a systematic analysis of the Global Burden of Diseases Study 2023.

EClinicalMedicine·2026
Same author

Cause-specific years of life lost attributable to non-optimal body mass index by county, sex, race, and ethnicity in the USA, 2000-2019: a systematic analysis of health disparities.

BMC medicine·2026
Same journal

Novel Parent Survey Measures Sensory Behaviors Incorporating Sensory Modality and Stimulus Intensity.

Heliyon·2026
Same journal

Expression of concern: "SQSTM1/p62 promotes the progression of gastric cancer through epithelial-mesenchymal transition" [Heliyon 10 (2024) e24409].

Heliyon·2026
Same journal

Expression of concern: "TL1A promotes metastasis and EMT process of colorectal cancer" [Heliyon 10 (2024) e24392].

Heliyon·2026
Same journal

Expression of concern: "Factors affecting timing of surgery following neoadjuvant chemoradiation for esophageal cancer" [Heliyon 9 (2023) e23212].

Heliyon·2026
Same journal

Expression of concern: "On stratified single-valued soft topogenous structures" [Heliyon 10 (2024) e27926].

Heliyon·2026
Same journal

Expression of concern: "Artifact removal and motor imagery classification in EEG using advanced algorithms and modified DNN" [Heliyon 10 (2024) e27198].

Heliyon·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.6K

Creating the vaccination improvement potential index.

Francisco Rios Casas1, Jacob Armitage1, Joanna Yuan1

  • 1Population Health Initiative, Hans Rosling Center for Population Health, University of Washington, Box 351622, 3980 15th Ave NE, Seattle, WA, 98195, USA.

Heliyon
|August 16, 2024
PubMed
Summary
This summary is machine-generated.

A new Vaccination Improvement Potential (VIP) Index helps assess countries' capacity for better immunization rates. The index, using health financing and socio-demographic data, shows improvements over time, guiding resource allocation for global vaccination efforts.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.6K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

Related Experiment Videos

Last Updated: Jun 16, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.6K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.6K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

Area of Science:

  • Global Health
  • Public Health Policy
  • Immunization Programs

Background:

  • Social and behavioral factors significantly influence vaccination coverage rates globally.
  • Existing measures do not comprehensively capture a nation's capacity to enhance or sustain immunization coverage.

Purpose of the Study:

  • To introduce and validate the Vaccination Improvement Potential (VIP) Index, a novel metric for assessing a country's potential to improve vaccination coverage.
  • To analyze trends in vaccination improvement potential across countries over three decades.

Main Methods:

  • The VIP Index was calculated using the geometric mean of 13 indicators related to health financing, vaccine confidence, and socio-demographics.
  • Data encompassed over 200 countries spanning 30 years, from 1990 to 2019.

Main Results:

  • The global mean VIP score increased from 0.49 in 1990 to 0.59 in 2019.
  • High-performing regions included Western Europe, North America, and East Asia.
  • Key factors influencing trends included vaccine hesitancy and disparities in health spending and development assistance, particularly in sub-Saharan Africa.

Conclusions:

  • The VIP Index provides a unique tool for evaluating a country's capacity to achieve higher immunization rates.
  • This index can inform policymakers and health officials in resource allocation, impact assessment, and identifying nations needing support for vaccination coverage improvements.